Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-09-001736
Filing Date
2009-03-02
Accepted
2009-02-27 21:50:37
Documents
11
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 10-K g17390e10vk.htm 10-K 2211032
2 EX-10.88 g17390exv10w88.htm EX-10.88 588828
3 EX-10.89 g17390exv10w89.htm EX-10.89 201538
4 EX-10.90 g17390exv10w90.htm EX-10.90 484943
5 EX-21.1 g17390exv21w1.htm EX-21.1 3457
6 EX-23.1 g17390exv23w1.htm EX-23.1 3045
7 EX-31.1 g17390exv31w1.htm EX-31.1 9198
8 EX-31.2 g17390exv31w2.htm EX-31.2 9131
9 EX-32.1 g17390exv32w1.htm EX-32.1 4001
10 EX-32.2 g17390exv32w2.htm EX-32.2 3753
11 GRAPHIC g17390g1739001.gif GRAPHIC 8099
  Complete submission text file 0000950144-09-001736.txt   3531604
Mailing Address 501 FIFTH ST BRISTOL TN 37620
Business Address 501 FIFTH ST BRISTOL TN 37620 4239898000
KING PHARMACEUTICALS INC (Filer) CIK: 0001047699 (see all company filings)

EIN.: 541684963 | State of Incorp.: TN | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15875 | Film No.: 09645200
SIC: 2834 Pharmaceutical Preparations